Life science fund raises over EUR 20 million

  • Share on Twitter
  • Share on LinkedIn

Inveni Capital, a new Finnish-German venture capital company, raised over EUR 20 million for its Inveni Life Sciences Fund l in the first round of fund-raising. First-round investors included Finnish Industry Investment Ltd, the University of Helsinki’s funds, private investors and other funds. The fund-raising will continue and the fund’s target size is EUR 50–70 million.


Inveni Life Sciences Fund I invests in early- and growth-stage life science companies that have a good opportunity of international success. Inveni Capital focuses its investments on medical technology companies operating in Northern and continental Europe, and on pharmaceutical companies, with the emphasis on Finland and Germany.



More information:


Inveni Capital, Helsinki office:
Markku Fagerlund, Partner
Cultivator I, Viikinkaari 6,
FIN-00790 Helsinki, Finland
+358 400 874546
mfagerlund (at)

Inveni Capital, Munich office:
Dr. Wolfgang Pieken, Partner
Zweibrückenstr. 8
D-80331 Munchen, Germany
+49 89 2351 5702
wpieken (at)